Viewing data from:

KANTREX

ANDA

KANAMYCIN SULFATE | A061655 | APOTHECON INC DIV BRISTOL MYERS SQUIBB

3 strengths0 unique patents0 unique exclusivities

API Supply Chain1 active DMF4 inactive

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO LTDKANAMYCIN SULFATE

DMF 282752014

BRISTOL MYERS SQUIBB COInactiveKANAMYCIN SULFATE

DMF 133251998

MEIJI SEIKA KAISHA LTDInactiveKANAMYCIN SULFATE

DMF 133921998

PIERREL AMERICA INCInactiveKANAMYCIN SULFATE

DMF 135991998

SHANGHAI ASIA PIONEER PHARMACEUTICALS CO LTDInactiveKANAMYCIN SULFATE

DMF 136281998

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — EQ 500MG BASE/2ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.

#002 — EQ 1GM BASE/3ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Approved Prior to Jan 1, 1982

#003 — EQ 75MG BASE/2ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Approved Prior to Jan 1, 1982